- Home
- NSA vs PTGX Comparison
NSA vs PTGX Comparison
Compare NSA & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- PTGX
- Stock Information
- Founded
- NSA 2013
- PTGX 2006
- Country
- NSA United States
- PTGX United States
- Employees
- NSA N/A
- PTGX N/A
- Industry
- NSA Real Estate Investment Trusts
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- NSA Real Estate
- PTGX Health Care
- Exchange
- NSA Nasdaq
- PTGX Nasdaq
- Market Cap
- NSA 2.7B
- PTGX 2.8B
- IPO Year
- NSA 2015
- PTGX 2016
- Fundamental
- Price
- NSA $36.66
- PTGX $42.97
- Analyst Decision
- NSA Hold
- PTGX Strong Buy
- Analyst Count
- NSA 10
- PTGX 8
- Target Price
- NSA $41.28
- PTGX $66.50
- AVG Volume (30 Days)
- NSA 691.9K
- PTGX 990.2K
- Earning Date
- NSA 05-05-2025
- PTGX 05-06-2025
- Dividend Yield
- NSA 6.20%
- PTGX N/A
- EPS Growth
- NSA N/A
- PTGX N/A
- EPS
- NSA 0.12
- PTGX 0.86
- Revenue
- NSA $742,357,000.00
- PTGX $207,801,000.00
- Revenue This Year
- NSA N/A
- PTGX N/A
- Revenue Next Year
- NSA $3.83
- PTGX $7.13
- P/E Ratio
- NSA $303.81
- PTGX $50.68
- Revenue Growth
- NSA N/A
- PTGX N/A
- 52 Week Low
- NSA $30.88
- PTGX $24.22
- 52 Week High
- NSA $49.44
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- NSA 50.62
- PTGX 43.08
- Support Level
- NSA $35.92
- PTGX $41.29
- Resistance Level
- NSA $38.14
- PTGX $46.12
- Average True Range (ATR)
- NSA 0.97
- PTGX 1.83
- MACD
- NSA 0.07
- PTGX -0.19
- Stochastic Oscillator
- NSA 43.08
- PTGX 27.81
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.